https://www.selleckchem.com/pr....oducts/chaetocin.htm
To characterize the association of preoperative functional performance status based on Eastern Cooperative Oncology Group (ECOG) scoring with the risk of adverse cardiovascular events, vascular events, and mortality in patients undergoing EVAR and TEVAR. Retrospective review of the Society for Vascular Surgery Vascular Quality Initiative, a large, multi-center, registry database was performed. All individuals undergoing EVAR (  = 18,73 and TEVAR (  = 6595) for non-ruptured aortic pathologies between 2014 and 2018 were eligible for a